Stay updated on Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    A consolidated Locations section has been added listing study sites in Arizona, District of Columbia, Minnesota, Missouri, New York, South Dakota, and Texas, and the page revision updated to v3.3.3. The previous state-specific subsections (Arizona Locations, District of Columbia Locations, Minnesota Locations, Missouri Locations, New York Locations, South Dakota Locations, Texas Locations) and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.9%
    Check dated 2025-12-23T23:59:31.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.1 to v3.3.2; no changes to the study content or structure were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T12:53:28.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The change is a minor revision log update from v3.2.0 to v3.3.1; no modifications to core study details, eligibility criteria, or outcome measures are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:10:26.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page no longer displays the administrative notice about government funding and NIH operating status; core study information such as objectives, eligibility, and locations remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:20:47.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    No significant changes detected in core study information (eligibility criteria, locations, primary/secondary outcomes, or overall study description). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:10.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T09:01:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Small Bowel Adenocarcinoma Clinical Trial page.